drugset / Trial / NCT00838383
Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a multi-center, randomized study of sitaxsentan administered intravenously to subjects who are undergoing elective CABG, cardiac valve replacement, or combined CABG and cardiac valve replacement procedures that require CPB.
Timeline
- Start
- 2006-08-10
- Primary completion
- 2008-03-31
- Completion
- 2008-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sitaxentan | Small molecule | 1 mg/kg | Intravenous |
| Subject | Sitaxentan | Small molecule | 2 mg/kg | Intravenous |
Indications
No indication recorded.